AgingResearch.News
AHA Scientific Sessions 2025 Abstract

Acoramidis Reduces All-Cause Mortality and Cardiovascular-Related Hospitalizations Through Month 42 in Transthyretin Amyloid Cardiomyopathy Across All Pre-specified Patient Subgroups

By Lily Kagan Stern, Amrut V. Ambardekar, Justin Lee Grodin, Show 8 more authorsMartha A. Grogan
Trial in peopleInterventions
Paper

The paper

Lily Kagan Stern, Amrut V. Ambardekar, Justin Lee Grodin, Show 8 more authorsMartha A. Grogan

Cedars-Sinai Medical Center; Mayo Clinic

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4364102

doi.org/10.1161/circ.152.suppl_3.4364102

More in Interventions